首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1904183

糖尿病护理设备市场规模、份额和成长分析（按类型、通路、最终用途和地区划分）—产业预测（2026-2033 年）

Diabetes Device Market Size, Share, and Growth Analysis, By Type (BGM Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球糖尿病护理设备市场规模将达到 362.3 亿美元，到 2025 年将达到 394.2 亿美元，到 2033 年将达到 774 亿美元，预测期（2026-2033 年）的复合年增长率为 8.8%。

由于都市化加速和久坐生活方式的盛行，全球糖尿病负担日益加重。许多患者如今都患有糖尿病，而糖尿病往往伴随中风、心血管疾病、神经病变和感染疾病等严重的健康併发症。人们对糖尿病管理的日益重视凸显了对旨在有效控制疾病和预防併发症的先进医疗设备的迫切需求。因此，市场对包括高阶胰岛素帮浦和胰岛素笔在内的先进胰岛素输注系统的需求不断增长，这反映出糖尿病照护领域正朝着创新解决方案的方向发展。领先的製造商正策略性地专注于技术进步，并开发突破性产品，以期在快速成长的糖尿病设备市场中占据重要份额。

全球糖尿病设备市场驱动因素

全球糖尿病患者数量的不断增长是推动糖尿病设备市场扩张的主要动力。久坐不动的生活方式、不良饮食习惯、肥胖率上升以及人口老化等因素共同导致糖尿病患者数量快速增长。这一成长趋势促使人们对能够有效管理和监测糖尿病的先进设备的需求日益增长。随着越来越多的患者寻求糖尿病管理方案，对创新设备的需求持续攀升，推动市场成长，并激励製造商开发新技术以应对这一紧迫的医疗挑战。

限制全球糖尿病设备市场的因素

有效的糖尿病管理高度依赖糖尿病管理设备的准确性和可靠性。然而，测量误差、校准问题或技术故障都可能出现，进而影响设备所提供资料的可靠性。这些不准确性可能导致错误的治疗决策，并危及病人安全。为了增强医护人员和糖尿病患者的信任，製造商必须优先考虑设备的准确性和可靠性。提高这些因素不仅有助于有效治疗，还能增强整个医疗保健系统对糖尿病管理工具的信任。

全球糖尿病设备市场趋势

全球糖尿病设备市场正呈现将先进技术融入胰岛素输注系统的显着趋势，尤其是在胰岛素帮浦和胰岛素笔的创新方面。能够与持续血糖监测（CGM）系统无缝整合的智慧胰岛素输注系统的出现，正在革新糖尿病管理。这些先进设备可根据即时血糖值读数自动调整胰岛素剂量，进而提高使用者的便利性和准确性。因此，患者可以受益于个人化的胰岛素剂量，进而改善血糖控制和整体健康。这种技术进步正在推动市场对更聪明、更互联的糖尿病管理解决方案的需求。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic（Ireland）
Abbott Laboratories（United States）
DexCom（United States）
Novo Nordisk（Denmark）
Becton, Dickinson and Company（United States）
Roche（Switzerland）
Insulet（United States）
Tandem Diabetes Care（United States）
Ypsomed（Switzerland）
Sanofi（France）
Eli Lilly and Company（United States）
LifeScan（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bayer AG（Germany）
Johnson & Johnson（United States）
Terumo Corporation（Japan）
AgaMatrix Holdings（United States）
ARKRAY USA（United States）
Nipro Corporation（Japan）

结论与建议

简介目录

Product Code: SQMIG35B2125

Global Diabetes Device Market size was valued at USD 36.23 Billion in 2024 and is poised to grow from USD 39.42 Billion in 2025 to USD 77.4 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global burden of diabetes is intensifying, driven by increasing urbanization and sedentary lifestyles. Currently, a significant population is living with diabetes, which is often linked to serious health complications such as stroke, cardiovascular disease, nerve damage, and infections. This growing awareness of diabetes management emphasizes the necessity for advanced medical devices aimed at effective disease control and complication prevention. Consequently, there is a rising demand for sophisticated insulin delivery systems, including high-end pumps and pens, reflecting a shift towards innovative solutions in diabetes care. Leading manufacturers are strategically focusing on technological advancements and creating groundbreaking products to capture a substantial share of the burgeoning diabetes device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The increasing global prevalence of diabetes serves as a key catalyst for the expansion of the diabetes device market. A combination of factors, including sedentary lifestyles, poor dietary choices, rising obesity rates, and an aging demographic, is fueling the surge in diabetes cases. This growing incidence elevates the necessity for advanced diabetes devices designed for effective management and monitoring of the condition. As more individuals seek solutions to control their diabetes, the demand for innovative devices continues to rise, driving market growth and prompting manufacturers to develop technologies that cater to this pressing healthcare challenge.

Restraints in the Global Diabetes Device Market

The effectiveness of diabetes management heavily relies on the accuracy and reliability of diabetes devices. Unfortunately, variations in measurements, calibration challenges, or technical malfunctions can sometimes occur, undermining the dependability of the data these devices provide. Such inaccuracies can result in misguided treatment decisions, potentially jeopardizing patient safety. To foster confidence among healthcare professionals and those living with diabetes, it is imperative that manufacturers prioritize the consistent accuracy and reliability of their devices. Enhancing these factors not only supports effective treatment but also strengthens the overall trust in diabetes management tools within the healthcare ecosystem.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a notable trend toward the integration of advanced technology in insulin delivery systems, particularly through innovations in insulin pumps and pens. The emergence of smart insulin delivery systems, which seamlessly connect with continuous glucose monitoring (CGM) systems, is revolutionizing diabetes management. These sophisticated devices facilitate automated insulin adjustments based on real-time glucose readings, enhancing user convenience and accuracy. As a result, patients benefit from personalized insulin delivery, leading to improved glycaemic control and overall health outcomes. This technological evolution underscores the growing demand for smarter, more interconnected diabetes management solutions in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2026-2033)

Market Overview
BGM Devices
- Self-Monitoring Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters
- Receiver
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

Global Diabetes Device Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers
Homecare

Global Diabetes Device Market Size & CAGR (2026-2033)

North America (Type, Distribution Channel, End Use)
- US
- Canada
Europe (Type, Distribution Channel, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Distribution Channel, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Distribution Channel, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Distribution Channel, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DexCom (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix Holdings (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments